Intracameral more effective than subconjunctival cefuroxime

Article

Intracameral cefuroxime is a safe alternative to subconjunctival cefuroxime and leads to a lower rate of endophthalmitis, claims a study published in the March 2008 issue of the Journal of Cataract & Refractive Surgery.

Intracameral cefuroxime is a safe alternative to subconjunctival cefuroxime and leads to a lower rate of endophthalmitis, claims a study published in the March 2008 issue of the Journal of Cataract & Refractive Surgery.

Patrick Yu-Wai-Man and colleagues at the Sunderland Eye Infirmary, UK, performed a retrospective analysis of all presumed infectious endophthalmitis cases from January 1, 2000, to December 31, 2006, and compared the rate of presumed infectious endophthalmitis in patients receiving subconjunctival cefuroxime with those receiving intracameral cefuroxime at the end of surgery.

The study, whose purpose was to compare the efficacy of intracameral cefuroxime versus subconjunctival cefuroxime in reducing the rate of endophthalmitis after cataract surgery, included 36 743 phacoemulsification cataract procedures, with a mean rate of presumed infectious endophthalmitis of 0.95 per 1000 cases. The incidence of endophthalmitis was significantly higher in the subconjunctival cefuroxime group than in the intracameral cefuroxime group.

Overall, the researchers found that intracameral cefuroxime was a safe alternative to subconjunctival cefuroxime and led to a lower rate of endophthalmitis.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Jeremiah Tao, MD, FACS, discusses his Egyptian Ophthalmological Society keynote, which focused on risk management and avoiding surgical complications in oculofacial surgery
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.